On Monday, Legend Biotech Corp ADR (NASDAQ: LEGN) opened lower -6.01% from the last session, before settling in for the closing price of $35.12. Price fluctuations for LEGN have ranged from $34.95 to $70.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 50.60%. Company’s average yearly earnings per share was noted 41.50% at the time writing. With a float of $181.93 million, this company’s outstanding shares have now reached $183.45 million.
The extent of productivity of a business whose workforce counts for 1826 workers is very important to gauge. In terms of profitability, gross margin is 60.75%, operating margin of -53.92%, and the pretax margin is -66.41%.
Legend Biotech Corp ADR (LEGN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Legend Biotech Corp ADR is 0.83%, while institutional ownership is 49.50%. The most recent insider transaction that took place on Dec 02 ’24, was worth 189,080. Before that another transaction happened on Sep 25 ’24, when Company’s Officer proposed sale 1,504 for $44.10, making the entire transaction worth $66,326.
Legend Biotech Corp ADR (LEGN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.50% per share during the next fiscal year.
Legend Biotech Corp ADR (NASDAQ: LEGN) Trading Performance Indicators
Check out the current performance indicators for Legend Biotech Corp ADR (LEGN). In the past quarter, the stock posted a quick ratio of 4.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.91, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of Legend Biotech Corp ADR (LEGN)
The latest stats from [Legend Biotech Corp ADR, LEGN] show that its last 5-days average volume of 1.75 million was superior to 1.13 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 2.52%. Additionally, its Average True Range was 2.09.
During the past 100 days, Legend Biotech Corp ADR’s (LEGN) raw stochastic average was set at 1.00%, which indicates a significant decrease from 2.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.09% in the past 14 days, which was higher than the 48.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $42.48, while its 200-day Moving Average is $49.05. Now, the first resistance to watch is $34.67. This is followed by the second major resistance level at $36.34. The third major resistance level sits at $37.30. If the price goes on to break the first support level at $32.04, it is likely to go to the next support level at $31.08. Assuming the price breaks the second support level, the third support level stands at $29.41.
Legend Biotech Corp ADR (NASDAQ: LEGN) Key Stats
There are currently 182,634K shares outstanding in the company with a market cap of 6.06 billion. Presently, the company’s annual sales total 285,140 K according to its annual income of -518,250 K. Last quarter, the company’s sales amounted to 160,210 K and its income totaled -125,320 K.
